Keep away from concomitant use of tucatinib with CYP3A substrates, the place minimum focus alterations might produce critical or life-threatening toxicities. If unavoidable, cut down CYP3A substrate dose In keeping with solution labeling.darifenacin will boost the level or effect of triazolam by influencing hepatic/intestinal enzyme CYP3A4 metaboli